HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Julio Vorobioff Selected Research

Rifaximin (L 105)

4/2023Norfloxacin prophylaxis effect on multidrug resistance in patients with cirrhosis and bacterial infections.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Julio Vorobioff Research Topics

Disease

5Infections
12/2023 - 09/2012
3Fibrosis (Cirrhosis)
12/2023 - 04/2019
3Bacterial Infections (Bacterial Infection)
12/2023 - 04/2019
2Cross Infection (Nosocomial Infection)
12/2023 - 04/2023
2Pneumonia (Pneumonitis)
12/2023 - 01/2021
2Ascites
12/2023 - 04/2023
1Shock
12/2023
1Inflammation (Inflammations)
12/2023
1Healthcare-Associated Pneumonia
12/2023
1Mycoses (Diseases, Fungus)
12/2023
1Brain Diseases (Brain Disorder)
04/2023
1Hepatitis
02/2023
1Urinary Tract Infections (Urinary Tract Infection)
02/2023
1Peritonitis
01/2021
1Liver Diseases (Liver Disease)
10/2019
1Liver Cirrhosis (Hepatic Cirrhosis)
09/2012

Drug/Important Bio-Agent (IBA)

4Anti-Bacterial Agents (Antibiotics)IBA
12/2023 - 04/2019
1Serum AlbuminIBA
12/2023
1C-Reactive ProteinIBA
12/2023
1NorfloxacinFDA Link
04/2023
1Proton Pump InhibitorsIBA
04/2023
1SodiumIBA
04/2023
1Rifaximin (L 105)FDA Link
04/2023
1Transaminases (Aminotransferases)IBA
02/2023
1EnzymesIBA
02/2023
1Nitrofurantoin (Macrodantin)FDA LinkGeneric
02/2023
1dimemorfan (AT 17)IBA
10/2019
1HLA-DRB1 Chains (HLA DRB1)IBA
09/2012

Therapy/Procedure

1Therapeutics
12/2023
1Critical Care (Surgical Intensive Care)
04/2023
1Liver Transplantation
04/2023